Karnataka villagers suspect biodiversity register

Government's agri-research set-up is undemocratic

India, US tie their first IPR knot

Water in a sieve

Don’t confine global resources to national boundaries

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents

Public Funded R&D Bill may benefit the private sector

Free trade will bind India

Legislation for a few

Benefits of the Act that encourages conservation of plants reach few farmers

Yale guide to fighting drug patent barriers

How human rights can be used to challenge oppressive intellectual property laws

Branding from origin

The French system of orgin labelling can be adopted for Indian medicine

Novartis exposes India's weak patent laws. Will generics be kicked out?

Rajasthan opens farm gates

State ties up with Monsanto, other biotech giants to restructure agriculture

Whose germplasm is it?

NBA struggles to frame case against Mahyco in first biopiracy case

MAHYCO refuses to share safety data on GM crops

Say cheese to Brussels

Letters

Beyond failure

What of the Doha round? What of the WTO itself?

In the snakepit

How negotiations on issues moved, or didn't

Big tobacco blows new smoke rings

A third front has opened up in their war on Australia’s cigarette packaging rules

News 360° - Briefs

News 360° - Briefs